This online curriculum provides up-to-date information related to the comprehensive care of people living with multiple sclerosis (MS) in rural areas. Led by expert faculty with extensive experience in both MS care and rural health, it is designed to address the unique challenges faced by nursing professionals practicing in rural areas. Many of these challenges …
Author Archives: Jenn Pichardo
What Is Disease Modifying Therapy? Evidence-Based Disease Modification in Multiple Sclerosis
RELEASE DATE: December 30, 2020 VALID FOR CREDIT THROUGH: December 30, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by an independent education grant from Sanofi Genzyme. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — maximum of 1.0 contact hours of continuing nursing …
IJMSC: I Will Respect the Autonomy of My Patient: A Scoping Review of Shared Decision Making in Multiple Sclerosis
Release Date: December 1, 2020 Valid for Credit Through: December 1, 2021 I Will Respect the Autonomy of My Patient: A Scoping Review of Shared Decision Making in Multiple Sclerosis Anne Christin Rahn, PhD; Alessandra Solari, MD; Heleen Beckerman, PhD; Richard Nicholas, PhD; David Wilkie, PhD; Christoph Heesen, MD; Andrea Giordano, MSc; for the Rehabilitation …
The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment
RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October 21, 2021 Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of the central nervous system characterized by immune-mediated demyelination and axonal damage predominantly targeting the optic nerves and spinal cord. To provide the most up-to-date information on the diagnosis and treatment of NMOSD, the …
Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care
Released: November 13, 2020 Expires: November 13, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by an independent education grant from Sanofi Genzyme. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — 1.0 Nursing Contact Hours Pharmacists — 1.0 Contact Hours (.1 CEUs) All other …
Continue reading “Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care”
Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management
Online, Virtual MeetingTuesday, December 8, 20207:00 pm EST Target Audience The target audience for the activity titled Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management is neurologists, nursing professionals, PAs and other healthcare professionals involved in the management of patients with MS. Learning Objectives Describe regulation and dysregulation of the adaptive and …
The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Nov. 16
Monday, November 16, 2020 12:00 – 1:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing …
The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Nov. 19
Thursday, November 19, 2020 4:00 – 6:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing …
Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …
Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …